DK170334B1 - 2-Pyridonderivater og tautomere og syreadditionssalte deraf, fremgangsmåde til fremstilling deraf, farmaceutiske præparater med indhold deraf samt anvendelse af 2-pyridonderivaterne til fremstilling af farmaceutiske præparater - Google Patents

2-Pyridonderivater og tautomere og syreadditionssalte deraf, fremgangsmåde til fremstilling deraf, farmaceutiske præparater med indhold deraf samt anvendelse af 2-pyridonderivaterne til fremstilling af farmaceutiske præparater Download PDF

Info

Publication number
DK170334B1
DK170334B1 DK133687A DK133687A DK170334B1 DK 170334 B1 DK170334 B1 DK 170334B1 DK 133687 A DK133687 A DK 133687A DK 133687 A DK133687 A DK 133687A DK 170334 B1 DK170334 B1 DK 170334B1
Authority
DK
Denmark
Prior art keywords
propyl
alkyl
hydroxy
pyridon
formula
Prior art date
Application number
DK133687A
Other languages
Danish (da)
English (en)
Other versions
DK133687D0 (da
DK133687A (da
Inventor
Georg Von Sprecher
Peter Waldmeier
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK133687D0 publication Critical patent/DK133687D0/da
Publication of DK133687A publication Critical patent/DK133687A/da
Application granted granted Critical
Publication of DK170334B1 publication Critical patent/DK170334B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK133687A 1986-03-17 1987-03-16 2-Pyridonderivater og tautomere og syreadditionssalte deraf, fremgangsmåde til fremstilling deraf, farmaceutiske præparater med indhold deraf samt anvendelse af 2-pyridonderivaterne til fremstilling af farmaceutiske præparater DK170334B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH108486 1986-03-17
CH108486 1986-03-17
CH226986 1986-06-04
CH226986 1986-06-04

Publications (3)

Publication Number Publication Date
DK133687D0 DK133687D0 (da) 1987-03-16
DK133687A DK133687A (da) 1987-09-18
DK170334B1 true DK170334B1 (da) 1995-08-07

Family

ID=25686601

Family Applications (1)

Application Number Title Priority Date Filing Date
DK133687A DK170334B1 (da) 1986-03-17 1987-03-16 2-Pyridonderivater og tautomere og syreadditionssalte deraf, fremgangsmåde til fremstilling deraf, farmaceutiske præparater med indhold deraf samt anvendelse af 2-pyridonderivaterne til fremstilling af farmaceutiske præparater

Country Status (18)

Country Link
US (1) US4863938A (fi)
EP (1) EP0239533B1 (fi)
JP (1) JPH0662566B2 (fi)
KR (1) KR910000658B1 (fi)
AU (1) AU601401B2 (fi)
CA (1) CA1312869C (fi)
DE (1) DE3781705D1 (fi)
DK (1) DK170334B1 (fi)
ES (1) ES2052601T3 (fi)
FI (1) FI86634C (fi)
GR (1) GR3006476T3 (fi)
HU (1) HU201913B (fi)
IE (1) IE59812B1 (fi)
IL (1) IL81903A0 (fi)
NO (1) NO172984C (fi)
NZ (1) NZ219629A (fi)
PH (1) PH25903A (fi)
PT (1) PT84490B (fi)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3073851A (en) * 1957-12-04 1963-01-15 Hoffmann La Roche Formamidines of primary amines
NL253634A (fi) * 1959-07-10
US3184482A (en) * 1961-11-20 1965-05-18 Hoffmann La Roche Anthraquinone formamidines of primary amines
US3182053A (en) * 1961-11-20 1965-05-04 Hoffmann La Roche Pyridine formamidines of primary amines
US3133078A (en) * 1961-11-20 1964-05-12 Hoffmann La Roche Oxazole formamidines of primary amines
GB1256714A (fi) * 1968-06-27 1971-12-15
US4186264A (en) * 1976-04-20 1980-01-29 Pfizer Inc. Triazapentadienes as acaricides
US4128652A (en) * 1976-04-20 1978-12-05 Pfizer Inc. Triazapentadienes as acaricides

Also Published As

Publication number Publication date
JPH0662566B2 (ja) 1994-08-17
CA1312869C (en) 1993-01-19
US4863938A (en) 1989-09-05
PH25903A (en) 1991-12-19
IE870687L (en) 1987-09-17
NO871075D0 (no) 1987-03-16
NZ219629A (en) 1990-03-27
AU601401B2 (en) 1990-09-13
DK133687D0 (da) 1987-03-16
NO172984C (no) 1993-10-06
PT84490A (en) 1987-04-01
PT84490B (pt) 1989-11-10
ES2052601T3 (es) 1994-07-16
HUT43823A (en) 1987-12-28
JPS62226959A (ja) 1987-10-05
NO871075L (no) 1987-09-18
FI871126A0 (fi) 1987-03-13
FI86634B (fi) 1992-06-15
DK133687A (da) 1987-09-18
FI871126A (fi) 1987-09-18
EP0239533A1 (de) 1987-09-30
KR910000658B1 (ko) 1991-01-31
KR870008850A (ko) 1987-10-21
FI86634C (fi) 1992-09-25
NO172984B (no) 1993-06-28
IE59812B1 (en) 1994-04-06
HU201913B (en) 1991-01-28
DE3781705D1 (de) 1992-10-22
IL81903A0 (en) 1987-10-20
EP0239533B1 (de) 1992-09-16
GR3006476T3 (fi) 1993-06-21
AU7007087A (en) 1987-09-24

Similar Documents

Publication Publication Date Title
US4171363A (en) 1,2,3-Thiadiazole process
US4101548A (en) 1,2,3-Thiadiazole amides
DE69411317T2 (de) Indoloylguanidinderivate als Inhibitoren des Natrium-Protonen Austauschs
EP0260817A1 (en) Quinazolinediones and pyridopyrimidinediones
NO170883B (no) Fremgangsmaate for fremstilling av 2-amino-5-hydroksy-4-metylpyrimidin-derivater
US5110818A (en) Anticonvulsive substituted-9-benzyl-9h-purines
JP2556722B2 (ja) 新規なスルホンアミド化合物
IE57057B1 (en) Carboxamides,process for their preparation and pharmaceutical preparations containing them
WO2003103671A1 (en) Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
EP0700911B1 (en) Imidazole derivatives having anti-HIV activity
EP0228845A2 (en) N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same
CZ113393A3 (en) Hiv protease inhibitor, useful for aids treatment, process of its preparation and pharmaceutical preparation in which said inhibitor is comprised
US4868175A (en) 4-Benzyl-1-(2H)-phthalazineone derivatives having an amino acid radical
JPH01313469A (ja) キナゾリン、その製法及びこれを含有する抗腫瘍作用を有する製薬学的組成物
US5576327A (en) Treatment of heart rhythym disorders by administration of 3-phenylsulfonyl-3, 7-diazabicyclo[3.3.1]nonane compounds
DK156722B (da) Analogifremgangsmaade til fremstilling af 2-piperazinopyrimidinderivater
JPH07188197A (ja) オキサゾール誘導体
DK170334B1 (da) 2-Pyridonderivater og tautomere og syreadditionssalte deraf, fremgangsmåde til fremstilling deraf, farmaceutiske præparater med indhold deraf samt anvendelse af 2-pyridonderivaterne til fremstilling af farmaceutiske præparater
NZ206696A (en) 1,2,3-triazole derivatives and pharmaceutical compositions
US5707979A (en) Phosphinic acid derivatives, their preparation and their use
NO165493B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolindioner og pyridopyrimidindioner.
US20100087496A1 (en) Novel cinnamic amide derivatives useful as ion channel modulators
DK141749B (da) Analogifremgangsmåde til fremstilling af pyridincarboxamidoethylbenzensulfonylurinstof-forbindelser.
CA2276310C (en) Process for the production of tetrazolylbenzopyrans
JP2001525398A (ja) 選択的β3アドレナリン作動性アゴニスト

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
B1 Patent granted (law 1993)
PBP Patent lapsed
AHB Application shelved due to non-payment